Imminent Webinar Template Updated
Hi {{firstName}},
Are you ready? It's almost time! {{webinarTitle}} kicks off at {{startTime}}.
In order to access tonight's webinar from your mobile device, kindly ensure that you are using the latest version of the EMGuidance app. Please visit your app store on your mobile device to upgrade to the latest version of EMGuidance. |
Quick overview of the webinar content: |
Join us for an insightful webinar with Prof Peter Collins, Professor of Clinical Cardiology and Consultant Cardiologist, as he explores the efficacy and safety of Ranolazine in patients with CCS.
By attending this webinar, you will:
- Gain insight into the rationale behind optimal medical therapy for patients with chronic coronary syndromes
- Explore the mechanism of action, clinical indications, and role of the metabolic antianginal Ranolazine in managing chronic coronary syndromes
- Receive an update on the 2024 ESC guidelines for the management of chronic coronary syndromes
|
Attendance is free and you will earn 1 Clinical CPD-point for attending. |
|
|
|
|
Click on the link below to join the webinar
|
|
|
|
| Join Webinar |
|
|
We look forward to seeing you there.
Best regards, The EMGuidance team |
|
|
|
|
|
West Tower, 2nd Floor, Nelson Mandela Square, Maude Street, Sandown, 2146 |
|
|
|
|
